Literature DB >> 7061882

Opsonic requirements for phagocytosis of Borrelia hermsii by human polymorphonuclear leukocytes.

P J Spagnuolo, T Butler, E H Bloch, C Santoro, J W Tracy, R C Johnson.   

Abstract

Opsonic requirements for phagocytosis by human polymorphonuclear leukocytes (PMNLs) of a laboratory strain of Borrelia hermsii were examined. Intracellular localization of spirochetes was confirmed by electron microscopy and cinephotomicroscopy. Phagocytosis of 3H-labeled spirochetes was increased with higher concentrations of pooled human serum or greater ratios of spirochetes to PMNLs and was unaffected by diminished classical complement pathway activity. Immune rabbit serum markedly increased phagocytosis of spirochetes beyond levels observed with preimmune rabbit serum. Immune rabbit serum also demonstrated direct activity against B. hermsii, which decreased the motility and viability and increased agglutination of the spirochetes independently of complement. Both the direct activity against B. hermsii and the opsonic activity of immune rabbit serum were eliminated by immunoabsorption of immunoglobulins. These observations suggest a role for the alternative complement pathway and for immunoglobulins in the opsonization of spirochetes for phagocytosis by PMNLs. Immunoglobulins may also play a role in the direct clearance of spirochetes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061882     DOI: 10.1093/infdis/145.3.358

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

Review 1.  B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.

Authors:  Matthew J Colombo; David Abraham; Akira Shibuya; Kishore R Alugupalli
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete.

Authors:  J L Benach; G S Habicht; B L Gocinski; J L Coleman
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

3.  Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite.

Authors:  Benjamin J Krajacich; Job E Lopez; Sandra J Raffel; Tom G Schwan
Journal:  Parasit Vectors       Date:  2015-10-21       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.